This is a Validated Antibody Database (VAD) review about rhesus mac.. CD40LG, based on 16 published articles (read how Labome selects the articles), using CD40LG antibody in all methods. It is aimed to help Labome visitors find the most suited CD40LG antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD40LG synonym: CD40L

BioLegend
mouse monoclonal (24-31)
  • flow cytometry; human; fig 3b
BioLegend CD40LG antibody (Biolegend, 310805) was used in flow cytometry on human samples (fig 3b). elife (2020) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD40LG antibody (Biolegend, 310826) was used in flow cytometry on human samples (fig 2b). elife (2020) ncbi
mouse monoclonal (24-31)
  • other; human; loading ...; fig 7a
BioLegend CD40LG antibody (BioLegend, 24-31) was used in other on human samples (fig 7a). elife (2019) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; loading ...; fig 4d
BioLegend CD40LG antibody (BioLegend, 24-31) was used in flow cytometry on human samples (fig 4d). J Exp Med (2019) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; loading ...; fig s3a
  • immunocytochemistry; human; loading ...; fig s2a
BioLegend CD40LG antibody (BioLegend, 310806) was used in flow cytometry on human samples (fig s3a) and in immunocytochemistry on human samples (fig s2a). Cell (2019) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; 1:100; loading ...; fig e8
BioLegend CD40LG antibody (Biolegend, 310805) was used in flow cytometry on human samples at 1:100 (fig e8). Nat Med (2019) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; loading ...; fig 8f
BioLegend CD40LG antibody (Biolegend, 24-31) was used in flow cytometry on human samples (fig 8f). Nat Commun (2018) ncbi
mouse monoclonal (24-31)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD40LG antibody (BioLegend, 24-31) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; loading ...; fig 1d
BioLegend CD40LG antibody (BioLegend, BLE310802) was used in flow cytometry on human samples (fig 1d). Oncoimmunology (2016) ncbi
mouse monoclonal (24-31)
  • flow cytometry; rhesus macaque; loading ...; fig s7c
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BioLegend CD40LG antibody (BioLegend, 310820) was used in flow cytometry on rhesus macaque samples (fig s7c). Science (2016) ncbi
mouse monoclonal (24-31)
  • flow cytometry; rhesus macaque; loading ...
In order to optimize vaccination with Aventis Pasteur's canarypox vector-HIV, BioLegend CD40LG antibody (BioLegend, 310808) was used in flow cytometry on rhesus macaque samples . Nat Med (2016) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; fig 1
In order to analyze HIV progression traits of a selective loss of early differentiated and highly functional PD1high CD4 T cells, BioLegend CD40LG antibody (BioLegend, 24-31) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; loading ...; fig 2b
In order to examine the effects of immunosuppressive agents on Polyomavirus BKV-specific T cells, BioLegend CD40LG antibody (Biolegend, 24-31) was used in flow cytometry on human samples (fig 2b). Kidney Int (2015) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human; fig 3
BioLegend CD40LG antibody (BioLegend, 24-31) was used in flow cytometry on human samples (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (24-31)
  • blocking or activating experiments; human
BioLegend CD40LG antibody (Biolegend, 24-31) was used in blocking or activating experiments on human samples . Cell Death Dis (2014) ncbi
mouse monoclonal (24-31)
  • flow cytometry; human
BioLegend CD40LG antibody (Biolegend, 24-31) was used in flow cytometry on human samples . Med Microbiol Immunol (2014) ncbi
Articles Reviewed
  1. Cui X, Ma C, Vasudevaraja V, Serrano J, Tong J, Peng Y, et al. Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy. elife. 2020;9: pubmed publisher
  2. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  3. Saliba D, Céspedes Donoso P, Balint S, Compeer E, Korobchevskaya K, Valvo S, et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. elife. 2019;8: pubmed publisher
  4. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed publisher
  5. Ahmed R, Omidian Z, Giwa A, Cornwell B, Majety N, Bell D, et al. A Public BCR Present in a Unique Dual-Receptor-Expressing Lymphocyte from Type 1 Diabetes Patients Encodes a Potent T Cell Autoantigen. Cell. 2019;177:1583-1599.e16 pubmed publisher
  6. Yang W, Lee K, Srivastava R, Kuo F, Krishna C, Chowell D, et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses. Nat Med. 2019;25:767-775 pubmed publisher
  7. Aulicino A, Rue Albrecht K, Preciado Llanes L, Napolitani G, Ashley N, Cribbs A, et al. Invasive Salmonella exploits divergent immune evasion strategies in infected and bystander dendritic cell subsets. Nat Commun. 2018;9:4883 pubmed publisher
  8. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  9. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  10. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  11. Vaccari M, Gordon S, Fourati S, Schifanella L, Liyanage N, Cameron M, et al. Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition. Nat Med. 2016;22:762-70 pubmed publisher
  12. Paris R, Petrovas C, Ferrando Martinez S, Moysi E, Boswell K, Archer E, et al. Selective Loss of Early Differentiated, Highly Functional PD1high CD4 T Cells with HIV Progression. PLoS ONE. 2015;10:e0144767 pubmed publisher
  13. Weist B, Wehler P, El Ahmad L, Schmueck Henneresse M, Millward J, Nienen M, et al. A revised strategy for monitoring BKV-specific cellular immunity in kidney transplant patients. Kidney Int. 2015;88:1293-1303 pubmed publisher
  14. Steindor M, Nkwouano V, Mayatepek E, Mackenzie C, Schramm D, Jacobsen M. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. PLoS ONE. 2015;10:e0119737 pubmed publisher
  15. Ramello M, Tosello Boari J, Canale F, Mena H, Negrotto S, Gastman B, et al. Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. Cell Death Dis. 2014;5:e1507 pubmed publisher
  16. Weist B, Schmueck M, Fuehrer H, Sattler A, Reinke P, Babel N. The role of CD4(+) T cells in BKV-specific T cell immunity. Med Microbiol Immunol. 2014;203:395-408 pubmed publisher